NON-INVASIVE, HIGH ACCURACY
Cardiac FILLING PRESSURE
MEASUREMENT and Monitoring
for heart failure patients
heart failue
A Huge Burden for Families and Society
6.9Million
Heart Failure (HF) Patients in the United States 1
75.4%
HF Mortality Rate in 5 Years 1
>1.1Million
HF Hospitalizations /year in the United States 2
65% of $30Billion
HF Hospitalization Costs of All Medical HF costs in 2020 1
References
1 Urbich M, Globe G, Pantiri K, et al. A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014–2020). PharmacoEconomics (2020) 38:1219–1236
2 Mozaffarian D, Benjamin EJ, Go AS, et al. Heart Disease and Stroke Statistics-2015 Update: A Report From the American Heart Association. Circulation. 2015;131:e29–e322
Filling pressure guided management is proven to reduce re-hospitalization
in heart failure patients.
Why CardioStory?
CardioStory combines patented, proprietary sensor technology with advanced algorithms to build a Non-Invasive Filling Pressure (NIFP) measurement and monitoring platform for heart failure patients.
Non-invasive
High Accuracy (mmHg) Cardiac Filling Pressure Measurement
Easy-to-use
Simple Measurement to Get Cardiac Filling Pressure in Two Minutes
Clinical Study
NIFP VS. Echocardiography
Using 18mmHg as cut-off value, the agreement rate is 83%, with 74% positive agreement rate and 86% negative agreement rate, p<0.0001.
NIFP VS. PCWP by Right Heart Catheterization
Using 18mmHg as cut-off value, the accuracy is 88%, with 71% sensitivity and 91% specificity, P<0.001. N=93.
CardioStory is committed to building a technology platform that addresses the full spectrum of cardiovascular care, including heart failure, atrial fibrillation, coronary artery disease, and more.
For Patients
We help people reduce hospital visits and improve their quality of life.
For Care Providers
Our advanced sensing technology helps healthcare providers monitor patients’ conditions outside the hospital and supports better disease management.
CardioStory Inc
hello@cardiostory.com